SCHEMBL9527893

SCHEMBL9527893

CC(C)(C)c1nc(C(=O)C2CCCCC2)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.37
AGTR2 P50052 2/20 0.37
SLC33A1 O00400 1/20 0.33
RIPK1 Q13546 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9530527 0.89 AGTR1 (0.39) AGTR1AGTR2SLC33A1
SCHEMBL9530272 0.87 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9527886 0.86 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL6006875 0.86 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9527802 0.85 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9700488 0.85 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9531952 0.85 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9532338 0.84 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9530088 0.84 AGTR1 (0.34) AGTR1AGTR2
SCHEMBL9529090 0.84 AGTR1 (0.34) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed